Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia

Journal of Infection

Volumn 73, Issue 2, 2016, Pages 107-114

  Cangemi, Roberto ^a   Pignatelli, Pasquale ^a   Carnevale, Roberto ^a   Bartimoccia, Simona ^a   Nocella, Cristina ^a   Falcone, Marco ^a   Taliani, Gloria ^a   Violi, Francesco ^a   Battaglia, Simona ^a   Bertazzoni, Giuliano ^a   Biliotti, Elisa ^a   Calabrese, Cinzia Myriam ^a   Casciaro, Marco ^a   De Angelis, Maurizio ^a   De Marzio, Paolo ^a   Esvan, Rozenn ^a   Fazi, Lucia ^a   Ferro, Domenico ^a   Fontanelli Sulekova, Lucia ^a   Franchi, Cristiana ^a   Giordo, Laura ^a   Grieco, Stefania ^a   Manzini, Elisa ^a   Morelli, Sergio ^a   Palange, Paolo ^a   Pastori, Daniele ^a   Rivano Capparuccia, Marco ^a   Romiti, Giulio Francesco ^a   Rossi, Elisabetta ^a   Ruscio, Eleonora ^a   Russo, Alessandro ^a   Scarpellini, Maria Gabriella ^a   Trapè, Stefano ^a   Toriello, Filippo ^a   more..

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Blood platelets; Endotoxins; NADPH oxidase; P selectin; Pneumonia

Indexed keywords

LIPOPOLYSACCHARIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SELECTIN; CYBB PROTEIN, HUMAN; MEMBRANE PROTEIN; PADGEM PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

AGE DISTRIBUTION; AGED; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DISEASE ASSESSMENT; DISEASE SEVERITY; DYSLIPIDEMIA; ENDOTOXEMIA; FEMALE; GUT PERMEABILITY; HUMAN; INTESTINE FUNCTION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN BLOOD LEVEL; THROMBOCYTE ACTIVATION; VERY ELDERLY; ADULT; BLOOD; COMMUNITY ACQUIRED INFECTION; COMPLICATION; GENETICS; INTESTINE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PERMEABILITY; PNEUMONIA;

ADULT; AGED; COMMUNITY-ACQUIRED INFECTIONS; ENDOTOXEMIA; FEMALE; HUMANS; INTESTINES; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NADPH OXIDASE; P-SELECTIN; PERMEABILITY; PLATELET ACTIVATION; PNEUMONIA;

EID: 84989842570     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2016.05.013     Document Type: Article

References (31)

1. 1 McCabe, C., Kirchner, C., Zhang, H., Daley, J., Fisman, D.N., Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med 169:16 (2009 Sep 14), 1525–1531.
2. 2 Corrales-Medina, V.F., Musher, D.M., Shachkina, S., Chirinos, J.A., Acute pneumonia and the cardiovascular system. Lancet 381:9865 (2013 Feb 9), 496–505.
3. 3 Cangemi, R., Casciaro, M., Rossi, E., Calvieri, C., Bucci, T., Calabrese, C.M., et al. Platelet activation is associated with myocardial infarction in patients with pneumonia. J Am Coll Cardiol 64:18 (2014 Nov 4), 1917–1925.
4. 4 Santos-Gallego, C.G., Picatoste, B., Badimon, J.J., Pathophysiology of acute coronary syndrome. Curr Atheroscler Rep, 16(4), 2014 Apr, 401.
5. 5 Patrono, C., Garcia Rodriguez, L.A., Landolfi, R., Baigent, C., Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353:22 (2005 Dec 1), 2373–2383.
6. 6 Kritselis, I., Tzanetakou, V., Adamis, G., Anthopoulos, G., Antoniadou, E., Bristianou, M., et al. The level of endotoxemia in sepsis varies in relation to the underlying infection: impact on final outcome. Immunol Lett 152:2 (2013 May), 167–172.
7. 7 Zhang, G., Han, J., Welch, E.J., Ye, R.D., Voyno-Yasenetskaya, T.A., Malik, A.B., et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 182:12 (2009 Jun 15), 7997–8004.
8. 8 Lopes-Pires, M.E., Casarin, A.L., Pereira-Cunha, F.G., Lorand-Metze, I., Antunes, E., Marcondes, S., Lipopolysaccharide treatment reduces rat platelet aggregation independent of intracellular reactive-oxygen species generation. Platelets 23:3 (2012), 195–201.
9. 9 Jain, S., Self, W.H., Wunderink, R.G., Fakhran, S., Balk, R., Bramley, A.M., et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373:5 (2015 Jul 30), 415–427.
10. 10 Fasano, A., Not, T., Wang, W., Uzzau, S., Berti, I., Tommasini, A., et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355:9214 (2000 Apr 29), 1518–1519.
11. 11 Fasano, A., Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clin Gastroenterol Hepatol 10:10 (2012 Oct), 1096–1100.
12. 12 Horan, T.C., Andrus, M., Dudeck, M.A., CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:5 (2008 Jun), 309–332.
13. 13 Aujesky, D., Fine, M.J., The pneumonia severity index: a decade after the initial derivation and validation. Clin Infect Dis 47:Suppl. 3 (2008 Dec 1), S133–S139.
14. 14 Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., Verschuren, M., et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33:13 (2012 Jul), 1635–1701.
15. 15 Loffredo, L., Marcoccia, A., Pignatelli, P., Andreozzi, P., Borgia, M.C., Cangemi, R., et al. Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease. Eur Heart J 28:5 (2007 Mar), 608–612.
16. 16 Rabe, K.F., Hurd, S., Anzueto, A., Barnes, P.J., Buist, S.A., Calverley, P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:6 (2007 Sep 15), 532–555.
17. 17 Pignatelli, P., Carnevale, R., Pastori, D., Cangemi, R., Napoleone, L., Bartimoccia, S., et al. Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2. Circulation 126:1 (2012 Jul 3), 92–103.
18. 18 Pignatelli, P., Carnevale, R., Di Santo, S., Bartimoccia, S., Sanguigni, V., Lenti, L., et al. Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction. Arterioscler Thromb Vasc Biol 31:2 (2011 Feb), 423–434.
19. 19 Rey, F.E., Cifuentes, M.E., Kiarash, A., Quinn, M.T., Pagano, P.J., Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(−) and systolic blood pressure in mice. Circ Res 89:5 (2001 Aug 31), 408–414.
20. 20 Breddin, H.K., Can platelet aggregometry be standardized?. Platelets 16:3–4 (2005 May–Jun), 151–158.
21. 21 Corrales-Medina, V.F., Musher, D.M., Wells, G.A., Chirinos, J.A., Chen, L., Fine, M.J., Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 125:6 (2012 Feb 14), 773–781.
22. 22 Santos-Gallego, C.G., Badimon, J.J., Cardiac complications after community-acquired pneumonia. Am J Cardiol, 117(2), 2016 Jan 15, 310.
23. 23 Violi, F., Cangemi, R., Calvieri, C., Pneumonia, thrombosis and vascular disease. J Thromb Haemost 12:9 (2014 Sep), 1391–1400.
24. 24 Cangemi, R., Calvieri, C., Falcone, M., Bucci, T., Bertazzoni, G., Scarpellini, M.G., et al. Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events. Am J Cardiol 116:4 (2015 Aug 15), 647–651.
25. 25 Corrales-Medina, V.F., Alvarez, K.N., Weissfeld, L.A., Angus, D.C., Chirinos, J.A., Chang, C.C., et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA 313:3 (2015 Jan 20), 264–274.
26. 26 Cangemi, R., Calvieri, C., Bucci, T., Carnevale, R., Casciaro, M., Rossi, E., et al. Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia?. Antioxid Redox Signal 20:18 (2014 Jun 20), 2949–2954.
27. 27 Violi, F., Sanguigni, V., Carnevale, R., Plebani, A., Rossi, P., Finocchi, A., et al. Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study. Circulation 120:16 (2009 Oct 20), 1616–1622.
28. 28 DeLeo, F.R., Renee, J., McCormick, S., Nakamura, M., Apicella, M., Weiss, J.P., et al. Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J Clin Invest 101:2 (1998 Jan 15), 455–463.
29. 29 Violi, F., Carnevale, R., Calvieri, C., Nocella, C., Falcone, M., Farcomeni, A., et al. Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia. Thorax 70:10 (2015 Oct), 961–966.
30. 30 Berg, R.D., The indigenous gastrointestinal microflora. Trends Microbiol 4:11 (1996 Nov), 430–435.
31. 31 Gurbel, P.A., Kreutz, R.P., Bliden, K.P., Tantry, U.S., Platelet activation and pneumonia: is soluble p-selectin the right marker?. J Am Coll Cardiol 65:14 (2015 Apr 14), 1492–1493.